Novità 21 déc 2017 Nuova procedura di valutazione della conformità negli Emirati Arabi Uniti La nuova valutazione della conformità si basa sulla limitazione dellʼutilizzo di sostanze pericolose in beni elettronici ed elettrici (RoHS: Rest...
News 29 mar 2023 Evolva launches new line for manufacturers of personal care products Evolva, a manufacturer of active ingredients, will be presenting its new product line for the personal care industry at the in-cosmetics trade fa...
News 22 jan 2024 DISCO Pharmaceuticals secures seed funding of 20 million euros DISCO Pharmaceuticals has secured seed funding of 20 million euros and officially launched the business. The team was the first to develop a meth...
News 18 déc 2023 UPM Biomedicals chooses the Basel Area as European bridgehead UPM Biomedicals is opening a lab on the Main Campus of Switzerland Innovation Park Basel Area. The Finnish company specializes in nanofibrillar c...
Aktuell 29 mar 2023 Evolva lanciert Serie für Hersteller von Körperpflege Der Wirkstoffhersteller Evolva stellt auf der Fachmesse in-cosmetics in Barcelona vom 28. bis 30. März sein neues Programm für die Körperpflegein...
ニュース 28 fév 2022 AIスキルの強化で組織力アップへ AI Master Class を提供中 AI、データ、自動化スキル、経営幹部スキルを発展させたい方は、ぜひAI Master Class オンラインプログラムをご活用ください。
Aktuell 13 déc 2017 Neues Verfahren zur Konformitätsbewertung in den Vereinigten Arabischen Emiraten Die neue Konformitätsbewertung bezieht sich auf die Beschränkung der Verwendung gefährlicher Inhaltsstoffe in elektronischen und elektrischen Güt...
News 14 aoû 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Report 27 aoû 2021 スイスの循環型経済 現在の直線型経済モデルは「take-make-waste」の原則に支配されています。その結果、生態系や天然資源への圧力が増しています。直線型経済モデルは、資源不足や資源の浪費を生み、最後には気候変動や生物多様性損失などの環境危機が生じます。人類は地球の限界(プラネタリー・バウンダリー)を超...
News 04 juil 2023 Top Stories from Western Switzerland (April-June 2023) From space exploration to medical breakthroughs and advancements in education and industry, discover Western Switzerland's top stories from April...
Novità 02 juin 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...
Spotlight 15 juin 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
スイスのテクノロジー + 産業 個別化された健康医療制度 ライフサイエンス分野および情報工学の長い伝統や、バリューチェーンを形成する高密度のエコシステムのおかげで、スイスには健康医療分野で新しくデジタル化を進める条件が整っています。
Global Opportunities 08 avr 2018 Opportunities in the Brazilian Agribusiness Following the current trend of Industry 4.0, Brazilian agribusiness sector – 30% of the country’s GDP – is becoming digital and is opening divers...
Research and Development 11 juil 2023 Benefit from R&D Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...
Global Opportunities 08 avr 2018 Opportunità nell’industria agricola brasiliana Seguendo l’attuale trend di Industria 4.0, il settore agricolo brasiliano, che costituisce il 30% del PIL del Paese, si sta digitalizzando sempre...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...